Replies to post #1957 on Diffusion Pharmaceuticals Inc (DFFN)

[Lighthouse]

Let the bleching and barering begin... Guess they are scammers too...lololol


Effective November 1, 2013, Sol J. Barer, Ph.D. and Isaac Blech were elected by the Company’s board of directors (the “Board”) as new directors. Dr. Barer was also named Chairman of the Board and Mr. Blech was named Vice Chairman of the Board. Dr. Barer and Mr. Blech have also been appointed to serve on the Company’s Audit and Compensation Committees. Their compensation as board members has not yet been determined. Also effective November 1, 2013, Jerold Rubinstein resigned as Chairman of the Board but remains as Chairman of the Board’s Audit Committee and Chief Executive Officer.

[Lighthouse]

Lol... Seems everyone owns common now.... Go figure.... Lol

5% Stockholders:
River Charitable Remainder Unitrust, West
Charitable Remainder Unitrust, Liberty
Charitable Remainder Trust Common 173,095,238(d) 41.0%
Sol Barer Common 45,833,333 10.9%
UTA Capital Common 32,604,024 7.7%
Paul Feller Common 24,255,000(e) 5.7%

Directors and Executive Officers:
Jerold Rubinstein, Chief Executive Officer Common 28,125,000(f) 6.3%
Randall Cross, Director Common 510,417(g) 0.1%
Michael Dunleavy, Sr., Director Common 483,333(h) 0.1%
Glenn Goldenberg, Director and Chairman of the Compensation Committee Common 956,944(i) 0.2%
Seymour Siegel, Director and Chairman of the Audit Committee Common 212,500(j) 0.1%
John Schneider, Director Common 662,500(k) 0.2%
John Moynahan, Chief Financial Officer Common 1,860,000(l) 0.4%
Timothy Boris, General Counsel Common 6,400,000(m) 1.5%
All Current Directors and Executive Officers as a Group (8 Persons) 39,210,694 8.6%